PE20030240A1 - DERIVADOS DE BENZO [g] QUINOLINA - Google Patents

DERIVADOS DE BENZO [g] QUINOLINA

Info

Publication number
PE20030240A1
PE20030240A1 PE2002000598A PE2002000598A PE20030240A1 PE 20030240 A1 PE20030240 A1 PE 20030240A1 PE 2002000598 A PE2002000598 A PE 2002000598A PE 2002000598 A PE2002000598 A PE 2002000598A PE 20030240 A1 PE20030240 A1 PE 20030240A1
Authority
PE
Peru
Prior art keywords
formula
alkyl
refers
compound
quinoline
Prior art date
Application number
PE2002000598A
Other languages
English (en)
Spanish (es)
Inventor
Rudolf Markstein
Peter Gull
Villar Esteban Pombo
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PE20030240A1 publication Critical patent/PE20030240A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PE2002000598A 2001-07-09 2002-07-03 DERIVADOS DE BENZO [g] QUINOLINA PE20030240A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01116553 2001-07-09

Publications (1)

Publication Number Publication Date
PE20030240A1 true PE20030240A1 (es) 2003-04-16

Family

ID=8177978

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2002000598A PE20030240A1 (es) 2001-07-09 2002-07-03 DERIVADOS DE BENZO [g] QUINOLINA

Country Status (25)

Country Link
US (1) US7105528B2 (enExample)
EP (1) EP1419149B1 (enExample)
JP (2) JP5006505B2 (enExample)
KR (2) KR101069948B1 (enExample)
CN (1) CN1293071C (enExample)
AR (1) AR036131A1 (enExample)
AT (1) ATE443060T1 (enExample)
AU (1) AU2002328856B2 (enExample)
BR (1) BR0210894A (enExample)
CA (1) CA2452920C (enExample)
DE (1) DE60233740D1 (enExample)
EC (1) ECSP024377A (enExample)
ES (1) ES2330732T3 (enExample)
HU (1) HUP0400833A3 (enExample)
IL (2) IL159255A0 (enExample)
MX (1) MXPA03012039A (enExample)
MY (1) MY130656A (enExample)
NO (1) NO327549B1 (enExample)
NZ (1) NZ530314A (enExample)
PE (1) PE20030240A1 (enExample)
PL (1) PL208284B1 (enExample)
PT (1) PT1419149E (enExample)
RU (1) RU2300532C2 (enExample)
WO (1) WO2003006458A1 (enExample)
ZA (1) ZA200309642B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EG24415A (en) * 2002-03-07 2009-05-25 Novartis Ag Quinoline derivatives
JP2007504198A (ja) * 2003-09-05 2007-03-01 ノバルティス アクチエンゲゼルシャフト ベンゾ[g]キノリン誘導体とプロスタグランジン誘導体を含む、組成物
RU2438670C1 (ru) * 2010-12-24 2012-01-10 Государственное бюджетное образовательное учреждение высшего профессионального образования "Ростовский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации (ГБОУ ВПО "РостГМУ" Минздравсоцразвития России) Способ лечения ишемического варианта первичной открытоугольной глаукомы у лиц с миопической рефракцией
PT3713933T (pt) 2017-11-24 2026-05-19 H Lundbeck As Novos profrmacos de catecolamina para utilizao no tratamento de doena de parkinson
US11104697B2 (en) 2019-05-20 2021-08-31 H. Lundbeck A/S Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR,10AR)-7-hydroxy-1- propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
US11130775B2 (en) 2019-05-20 2021-09-28 H. Lundbeck A/S Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
US11168056B2 (en) 2019-05-20 2021-11-09 H. Lundbeck A/S Process for the manufacturing of (6aR,10aR)-7-propyl-6,6a,7,8,9,10,10a,11-octahydro-[1,3]dioxolo[4′,5′:5,6]benzo[1,2-G]quinoline and (4aR,10aR)-1-propyl-1,2,3,4,4a,5,10,10a-octahydro-benzo[G]quinoline-6,7-diol
US11111263B2 (en) 2019-05-20 2021-09-07 H. Lundbeck A/S Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
EP3972600B1 (en) 2019-05-21 2026-02-18 H. Lundbeck A/S Catecholamine carbamate prodrugs for use in the treatment of parkinson s disease
JP7641234B2 (ja) 2019-05-21 2025-03-06 ハー・ルンドベック・アクチエゼルスカベット パーキンソン病の治療に使用するための新規なカテコールアミンプロドラッグ
US12391650B2 (en) 2019-05-21 2025-08-19 H. Lundbeck A/S Catecholamine prodrugs for use in the treatment of Parkinson's disease
WO2020234275A1 (en) 2019-05-21 2020-11-26 H. Lundbeck A/S New catecholamine prodrugs for use in the treatment of parkinson's diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5262422A (en) * 1991-05-02 1993-11-16 Sandoz Ltd. Octahydrobenzo[g]quinoline
DE4114325A1 (de) * 1991-05-02 1992-11-05 Sandoz Ag Octahydrobenzo(g)chinolin, seine herstellung und verwendung
GB9326010D0 (en) 1993-12-21 1994-02-23 Sandoz Ltd Improvements in or relating to organic compounds
TW357143B (en) * 1995-07-07 1999-05-01 Novartis Ag Benzo[g]quinoline derivatives
TW378209B (en) * 1996-07-08 2000-01-01 Novartis Ag Benzo[g]quinoline derivatives, their preparation and the pharmaceutical composition containing them

Also Published As

Publication number Publication date
ZA200309642B (en) 2004-10-04
JP2010024243A (ja) 2010-02-04
DE60233740D1 (de) 2009-10-29
HK1066211A1 (en) 2005-03-18
US20040171628A1 (en) 2004-09-02
BR0210894A (pt) 2004-06-22
ATE443060T1 (de) 2009-10-15
CA2452920C (en) 2010-03-30
NO20040059L (no) 2004-01-07
NZ530314A (en) 2005-08-26
HUP0400833A2 (hu) 2004-07-28
CN1293071C (zh) 2007-01-03
PT1419149E (pt) 2009-11-25
MXPA03012039A (es) 2004-03-26
HUP0400833A3 (en) 2010-03-29
RU2004102398A (ru) 2005-07-10
WO2003006458A1 (en) 2003-01-23
NO327549B1 (no) 2009-08-10
RU2300532C2 (ru) 2007-06-10
JP2004538278A (ja) 2004-12-24
US7105528B2 (en) 2006-09-12
KR20040013126A (ko) 2004-02-11
PL208284B1 (pl) 2011-04-29
PL365254A1 (en) 2004-12-27
MY130656A (en) 2007-07-31
EP1419149A1 (en) 2004-05-19
IL159255A (en) 2010-05-17
IL159255A0 (en) 2004-06-01
KR20100007983A (ko) 2010-01-22
ECSP024377A (es) 2004-08-27
AR036131A1 (es) 2004-08-11
ES2330732T3 (es) 2009-12-15
JP5006505B2 (ja) 2012-08-22
KR101069948B1 (ko) 2011-10-04
EP1419149B1 (en) 2009-09-16
AU2002328856B2 (en) 2005-08-04
CA2452920A1 (en) 2003-01-23
CN1525969A (zh) 2004-09-01

Similar Documents

Publication Publication Date Title
AR018693A1 (es) MÉTODO PARA LA PREPARACIoN DE CITALOPRAM Y COMPUESTOS INTERMEDIARIOS PARA USO EN DICHO MÉTODO.
FR17C0003I1 (fr) Steroides comme agonistes de fxr
EA200301306A1 (ru) Производные 1-фенилсульфонил-1,3-дигидро-2h-индол-2-она, их получение и их терапевтическое применение
SI2428519T1 (sl) Sestavek za pripravo 17-vinil-triflatov kot intermediatov
WO2007137030A3 (en) Cns active fused bicycloheterocycle substituted azabicyclic alkane derivatives
PE20001467A1 (es) Derivados de 4-fenilpiridina como antagonistas del receptor de neuroquinina
AR029381A1 (es) Composicion para tratamiento de los desordenes de secrecion externa, metodo que la emplea y uso de un derivado de acido graso para prepararla
PE1998A1 (es) DERIVADOS DE BENZO [g] QUINOLINA
EA200300619A1 (ru) Серотонинергические средства
DE69924254D1 (de) Verwendung von a3-adenosine antagonisten zur herstellung eines arzneimittels zur senkung des augeninnendrucks
SU1568886A3 (ru) Cпocoб пoлучehия 1-фehил-3-haфtaлehилokcипpoпahamиhob или иx фapmakoлoгичeckи пpиemлemыx kиcлotho-aддиtиbhыx coлeй
ES8801245A1 (es) Un procedimiento para preparar derivados de piperidina
KR950011444A (ko) 갈란타민 유도체, 이의 제조방법 및 약제로서의 이의 용도
KR880012227A (ko) 도파민 수용체 길항제의 신규사용법
PE20091182A1 (es) DERIVADOS DE IMIDAZO[1,2-a]PIRIDIN-2-CARBOXAMIDAS, SU PREPARACION Y SU APLICACION EN TERAPEUTICA
PE20000724A1 (es) 1,2,3,4-tetrahidroquinolina
ATE239722T1 (de) Benzofurylpiperazine als serotonin-agonisten
AR036131A1 (es) Derivados de benzo (g) quinolina, un proceso para su preparacion, una composicion farmaceutica y el uso de dichos derivados para la fabricacion de un medicamento
BR9807520A (pt) Derivados de 5-aroilnaftaleno.
PE20070120A1 (es) Derivados de prostaglandina
SE8804688D0 (sv) Substituerade styrenderivat
AR038730A1 (es) Derivados de quinolina
NO20006350L (no) Derivater av 3-(2-okso-[1,3']bipyrrolidinyl-3-ylidenmetyl)- cephemer
KR960003719A (ko) 녹내장 치료제 및 안압 강하제
KR960017669A (ko) 양쪽성 3환식 화합물

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed